Trials / Completed
CompletedNCT00097578
A Study of Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Adenocarcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,953 (actual)
- Sponsor
- Genentech, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This is an observational study designed to follow patients with metastatic or locally advanced and unresectable colorectal cancer who are receiving Avastin in combination with chemotherapy and whose cancer has been either previously untreated or treated \<=4 months prior to enrollment.
Conditions
Timeline
- Start date
- 2004-03-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2004-11-25
- Last updated
- 2013-03-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00097578. Inclusion in this directory is not an endorsement.